Antibody Drug Conjugates Market Trends

Antibody Drug Conjugates Market Trends

Increasing prevalence of cancer worldwide have significantly created the demand for effective and targeted treatment options. Antibody drug conjugate offers unique approach by combining the specificity of monoclonal antibodies with the potency of cytotoxic drugs, intended to target and kill tumor cells while minimizing damage to healthy cells. Also, ADCs possess the potential to overcome drug resistance mechanisms observed in cancer cells, thereby increasing the effectiveness of treatment. Furthermore, antibody drug conjugate can be utilized in combination therapies and personalized medicine that allows patient specific treatment that aids to attain improved patient outcomes and enhance the patient quality of life.